Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In this study-level meta-analysis, we evaluated the clinical outcome with nonvitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs) in atrial fibrillation (AF) patients with cancer.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Thromb Haemost

Title: Thrombosis and haemostasis

Publisher: Georg Thieme Verlag KG

ISSN (Electronic): 2567-689X

ISSN (Print): 0340-6245

Publication date (Electronic): Feb 2020

Volume: 120

Issue: 2

Affiliations

[1 ] Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Rome, Italy.

[2 ] Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

[3 ] Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Article

DOI: 10.1055/s-0039-3400300

PubMed ID: 31785599

SO-VID: ff54e311-a9a5-4243-84aa-457574a6d0ef

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by